Conrad, M E <br/><br/>
Integrin beta3 blockade with abciximab and protection from myocardial ischemic events.  [electronic resource] 

 -  JAMA  Jan 1998 
 - 195-6 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>0098-7484 
<br/><br/><label>Standard No.: </label>10.1001/jama.279.3.195-a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, CD--drug effects<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Integrin beta3<br/>Integrins--antagonists & inhibitors<br/>Myocardial Ischemia--prevention & control<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Membrane Glycoproteins--drug effects